INT186840

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.15
First Reported 2005
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 5
Disease Relevance 2.67
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (FCGR1B)
Anatomy Link Frequency
macrophages 1
monocytes 1
FCGR1B (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 67 50.00 Quite Low
Multiple sclerosis 3 21.92 Low Low
headache 3 21.36 Low Low
cytokine 49 5.00 Very Low Very Low Very Low
corticosteroid 17 5.00 Very Low Very Low Very Low
chemokine 16 5.00 Very Low Very Low Very Low
iatrogenic 12 5.00 Very Low Very Low Very Low
withdrawal 6 5.00 Very Low Very Low Very Low
Central nervous system 3 5.00 Very Low Very Low Very Low
aspirin 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Convalescence 6 98.76 Very High Very High Very High
Contagious Ecthyma 183 97.76 Very High Very High Very High
Urological Neuroanatomy 22 89.36 High High
Infection 504 86.80 High High
Epstein-barr Virus 141 86.40 High High
Sarcoma 585 55.44 Quite High
INFLAMMATION 73 50.00 Quite Low
Acquired Immune Deficiency Syndrome Or Hiv Infection 339 48.48 Quite Low
Herpes Virus Infection 9 34.88 Quite Low
Ehrlichiosis 3 31.76 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Figure 3 shows the effect of 0.5 and 2 mg pretreatments with FP on O3-induced changes in the cell-surface markers CD11b, mCD14, CD64, CD16, HLA-DR, and CD86 on monocytes, macrophages, and DCs.
Regulation (effect) of CD64 in macrophages
1) Confidence 0.15 Published 2008 Journal Environ Health Perspect Section Body Doc Link PMC2430237 Disease Relevance 0.25 Pain Relevance 0
Figure 3 shows the effect of 0.5 and 2 mg pretreatments with FP on O3-induced changes in the cell-surface markers CD11b, mCD14, CD64, CD16, HLA-DR, and CD86 on monocytes, macrophages, and DCs.
Regulation (effect) of CD64 in monocytes
2) Confidence 0.05 Published 2008 Journal Environ Health Perspect Section Body Doc Link PMC2430237 Disease Relevance 0.25 Pain Relevance 0
Current HHV-8 ELISAs target IgG antibodies to one of three viral antigens: K8.1 [235], Orf 65 [59], or Orf 73 [235].
Regulation (target) of IgG associated with contagious ecthyma
3) Confidence 0.01 Published 2005 Journal Virol J Section Body Doc Link PMC1243244 Disease Relevance 0.66 Pain Relevance 0
Many patients show an EBNA2 IgG response during the acute phase, but an EBNA1 IgG response usually does not appear until convalescence [38].
Regulation (response) of IgG associated with convalescence
4) Confidence 0.01 Published 2005 Journal Virol J Section Body Doc Link PMC1243244 Disease Relevance 0.75 Pain Relevance 0
Many patients show an EBNA2 IgG response during the acute phase, but an EBNA1 IgG response usually does not appear until convalescence [38].
Regulation (response) of IgG associated with convalescence
5) Confidence 0.01 Published 2005 Journal Virol J Section Body Doc Link PMC1243244 Disease Relevance 0.75 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox